» Articles » PMID: 2433595

Glycine Potentiates the NMDA Response in Cultured Mouse Brain Neurons

Overview
Journal Nature
Specialty Science
Date 1987 Feb 5
PMID 2433595
Citations 637
Authors
Affiliations
Soon will be listed here.
Abstract

Transmitters mediating 'fast' synaptic processes in the vertebrate central nervous system are commonly placed in two separate categories that are believed to exhibit no interaction at the receptor level. The 'inhibitory transmitters' (such as glycine and GABA) are considered to act only on receptors mediating a chloride conductance increase, whereas 'excitatory transmitters' (such as L-glutamate) are considered to activate receptors mediating a cationic conductance increase. The best known excitatory receptor is that specifically activated by N-methyl-D-aspartate (NMDA) which has recently been characterized at the single channel level. The response activated by NMDA agonists is unique in that it exhibits a voltage-dependent Mg block. We report here that this response exhibits another remarkable property: it is dramatically potentiated by glycine. This potentiation is not mediated by the inhibitory strychnine-sensitive glycine receptor, and is detected at a glycine concentration as low as 10 nM. The potentiation can be observed in outside-out patches as an increase in the frequency of opening of the channels activated by NMDA agonists. Thus, in addition to its role as an inhibitory transmitter, glycine may facilitate excitatory transmission in the brain through an allosteric activation of the NMDA receptor.

Citing Articles

Modulation of the human GlyT1 by clinical drugs and cholesterol.

Li N, Wei Y, Li R, Meng Y, Zhao J, Bai Q Nat Commun. 2025; 16(1):2412.

PMID: 40069141 PMC: 11897355. DOI: 10.1038/s41467-025-57613-z.


TMS and EEG Pharmacodynamic Effects of a Selective Sphingosine-1-Phosphate Subtype 1 Receptor Agonist on Cortical Excitability in Healthy Subjects.

de Cuba C, de Goede A, Klaassen E, Otto M, Doll R, Kim J Clin Pharmacol Ther. 2024; 117(3):787-797.

PMID: 39641417 PMC: 11835432. DOI: 10.1002/cpt.3521.


Ischemic Stroke: Pathophysiology and Evolving Treatment Approaches.

Majumder D Neurosci Insights. 2024; 19:26331055241292600.

PMID: 39444789 PMC: 11497522. DOI: 10.1177/26331055241292600.


Targeting harmful effects of non-excitatory amino acids as an alternative therapeutic strategy to reduce ischemic damage.

Carretero V, Alvarez-Merz I, Hernandez-Campano J, Kirov S, Hernandez-Guijo J Neural Regen Res. 2024; 20(9):2454-2463.

PMID: 39314160 PMC: 11801293. DOI: 10.4103/NRR.NRR-D-24-00536.


Interactions Involving Glycine and Other Amino Acid Neurotransmitters: Focus on Transporter-Mediated Regulation of Release and Glycine-Glutamate Crosstalk.

Raiteri L Biomedicines. 2024; 12(7).

PMID: 39062091 PMC: 11275102. DOI: 10.3390/biomedicines12071518.